A larger proportion of HD patients than controls received 2 doses of the AZD1222 vaccine than the BNT162b2 (hereafter described as viral vector (VV) and mRNA vaccines (mRV), respectively), but this did not reach statistical significance, and the time interval between first and second vaccine doses was similar between controls and HD patients.
← all excerpts
Distinct Neutralising and Complement-Fixing Antibody Responses Can Be Induced to the Same Antigen in Haemodialysis Patients After Immunisation with Different Vaccine Platforms.
1
—
—